Free Trial
ASX:CU6

Clarity Pharmaceuticals (CU6) Stock Price, News & Analysis

Clarity Pharmaceuticals logo

About Clarity Pharmaceuticals Stock (ASX:CU6)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CU6 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarity Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CU6 Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:CU6
CIK
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$42.32 million
Net Margins
-481.09%
Pretax Margin
N/A
Return on Equity
-42.46%
Return on Assets
-24.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.05
Quick Ratio
13.19

Sales & Book Value

Annual Sales
A$11.51 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.51 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
319,670,000
Free Float
N/A
Market Cap
A$1.17 billion
Optionable
Not Optionable
Beta
1.58
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:CU6) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners